Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your Favorites.
This session is in your Favorites. Click again to remove it.
Presentation Icons
ACG Award Winner
ACG Newsworthy Abstract
Registration Required
No CME
On-Demand Video
Livestream
Back
Favorite
Email
Post (Tweet)
Peter Hur, PharmD
Pfizer Inc.
Poster(s):
P4373 - Understanding Patient Preferences at the Time of Treatment Escalation to First Line Advanced Therapies in Ulcerative Colitis: A Discrete Choice Experiment in Five European Countries
Tuesday, October 29, 2024
10:30 AM – 4:00 PM
ET
P4374 - Understanding Gastroenterologist Preferences at the Time of Treatment Escalation to First-Line Advanced Therapies in Ulcerative Colitis: A Discrete Choice Experiment in Five European Countries
Tuesday, October 29, 2024
10:30 AM – 4:00 PM
ET
P4375 - Matching-Adjusted Indirect Comparison of Etrasimod Versus Ozanimod for Clinical Response and Remission Among Patients With Moderately to Severely Active Ulcerative Colitis
Tuesday, October 29, 2024
10:30 AM – 4:00 PM
ET
Email Peter